SynBioVen
Venture capitalLondon · Pre-Seed–Series A · 4 people tracked
Investment thesis
SynBioVen invests at the earliest stages — proof-of-concept, pre-seed and seed — in synthetic biology ventures. The firm believes synthetic biology will power the next industrial revolution and the transition to a net-zero economy, with UK companies leading the way. Beyond capital, it offers portfolio companies access to a network of experts spanning synthetic biology research, business development and financing, a dedicated technical team at SynbiCITE, and use of the London Biofoundry R&D hub in West London to help startups de-risk and scale.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website
What they invest in
from 6 of 7 portfolio companiesBiotech ×6AI & Machine Learning ×5Cleantech ×2AgTech ×1Circular Economy ×1Climate Tech ×1Deep Tech ×1FoodTech ×1
HQs:United Kingdom×2United States×1
Investments · 7 tracked
founders shown can be your intro pathPartnerSir David Harding· solo GP
Co-investorsFuture Planet CapitalOxford Investment Opportunity Network (OION)
Colorifix uses engineered microorganisms to produce, deposit, and fix dyes on textiles through a biological fermentation process, aiming to reduce the environmental impact of textile dyeing.
BiotechCircular EconomyCleantechClimate TechNew MaterialsNorwich, GB
PartnerSir David Harding· solo GP
Co-investorsGOLDWIN VENTURE PARTNERSRegeneration.VC
Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.
AI & Machine LearningBiotech
PartnerSir David Harding· solo GP
Co-investorsUnruly Capital
Multus designs cell culture media for the industrial bioeconomy, applying AI, robotics, and biological expertise to media formulation.
AI & Machine LearningBiotechDeep TechFoodTechLondon, GB
PartnerSir David Harding· solo GP
Co-investorsBig Idea Ventures
Resurrect Bio develops genetic disease-resistance traits for crops by restoring plant R-genes, using its FloraFold AI platform and rapid in-planta screening for trait discovery.
AgTechAI & Machine LearningBiotech
Cian Duggan(CEO / Co-Founder)Tolga Bozkurt(Co-Founder)Sophien Kamoun(Co-Founder)
PartnerSir David Harding· solo GP
Co-investorsCalculus Capital Ltd.Future Planet CapitalUK Innovation & Science Seed FundAgFunder
Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing.
AI & Machine LearningBiotechCleantech
PartnerSir David Harding· solo GP
Co-investorsFarvatn Venture
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Founder)inIrsyad Khairil(Founder)in
PartnerSir David Harding· solo GP
Co-investorsHoxton VenturesLongeVCMetaplanetOxonian VenturesP53 InvestY Combinator+1 more
Portfolio news
latest coverage across their companiesValink Therapeutics · finsmes.com · Oct 20, 2025
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2022
Director · British · since 2022
Director · British · since 2022
Director · British · since 2022
David Winton Harding — 50–75% of shares, 50–75% of voting rights, right to appoint and remove directors
Frequently asked questions
- How many investments has SynBioVen made?
- SynBioVen has 7 tracked investments.
- What stage does SynBioVen invest at?
- SynBioVen invests at the Pre-Seed, Seed, Series A stages.
- What sectors does SynBioVen focus on?
- SynBioVen focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, FoodTech, IoT, Medical Devices, New Materials.
- Where is SynBioVen located?
- SynBioVen is headquartered in London, GB.
- Who does SynBioVen co-invest with?
- SynBioVen most often shares deals with Future Planet Capital, Hoxton Ventures, LongeVC, among 14 tracked co-investors.
Similar investors
Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
The Business Development Bank of Canada (BDC) is a Canadian institution that has supported small and medium-sized businesses for over 80 years, providing financing and advisory services to entrepreneurs across all industries and growth stages.
Vesna is a deep-tech venture fund, described as the first Slovenian-Croatian deep tech fund, backed by the European Investment Fund, investing in early-stage technologies spun out of Slovenian and Croatian R&D institutions.
Innovobot is an investment and innovation platform focused on deep tech, combining a venture fund (IRV), an innovation studio (Innovobot Labs), and engineering services to foster technologies that address social, industrial and environmental challenges.